Competitive Inoculation as an Effective Prophylaxis Against Recurrent Urinary Tract Infections: A Systematic Review
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Urinary tract infection (UTI) is a common condition defined as the presence of bacteria within the urine above a certain threshold (usually >100,000 m/L). The lifetime risk in women is estimated to be 50%, of whom 25% will develop recurrence within 6 months. Unfortunately, the use of antibiotics to treat and manage recurrent UTI (rUTI) is a growing problem, due to the burden of growing antibiotic resistance on public health. As such, new approaches to manage rUTI are being investigated and developed. Competitive inoculation via instillation of Escherichia coli 83972 or HU2117 in the bladder is a new prophylactic non-antimicrobial therapy for rUTIs. It utilizes the principle of the protective nature of asymptomatic bacteriuria to prevent recurrence of symptomatic UTIs. However, the effectiveness and safety of this technique remains unclear. This systematic review examined the current outcomes data on competitive inoculation as an effective and safe treatment for rUTI prophylaxis. Based on a limited number of studies, current evidence suggests that competitive inoculation is an effective and safe prophylactic measure against UTIs in a select group of patients with incomplete bladder emptying. However, administration of the technology is both resource and time intensive, and there is strong data demonstrating low successful colonisation rates. Competitive inoculation is an alternative to antibiotics only to rUTI patients with incomplete bladder emptying. There is no evidence to suggest that the technology would be suitable for other subsets of rUTI patients. Further randomized controlled trials should be conducted to improve the evidence base before drawing conclusions for clinical practice, and ideas to improve colonisation rates and simplify the administration process should be explored.
Abstract
Urinary tract infection (UTI) is a common condition defined as the presence of bacteria within the urine above a certain threshold (usually >100,000 m/L). The lifetime risk in women is estimated to be 50%, of whom 25% will develop recurrence within 6 months. Unfortunately, the use of antibiotics to treat and manage recurrent UTI (rUTI) is a growing problem, due to the burden of growing antibiotic resistance on public health. As such, new approaches to manage rUTI are being investigated and developed. Competitive inoculation via instillation of Escherichia coli 83972 or HU2117 in the bladder is a new prophylactic non-antimicrobial therapy for rUTIs. It utilizes the principle of the protective nature of asymptomatic bacteriuria to prevent recurrence of symptomatic UTIs. However, the effectiveness and safety of this technique remains unclear. This systematic review examined the current outcomes data on competitive inoculation as an effective and safe treatment for rUTI prophylaxis. Based on a limited number of studies, current evidence suggests that competitive inoculation is an effective and safe prophylactic measure against UTIs in a select group of patients with incomplete bladder emptying. However, administration of the technology is both resource and time intensive, and there is strong data demonstrating low successful colonisation rates. Competitive inoculation is an alternative to antibiotics only to rUTI patients with incomplete bladder emptying. There is no evidence to suggest that the technology would be suitable for other subsets of rUTI patients. Further randomized controlled trials should be conducted to improve the evidence base before drawing conclusions for clinical practice, and ideas to improve colonisation rates and simplify the administration process should be explored.
참고문헌 (43)
- Tan CW, "Urinary tract infections in adults", Singapore Med J, 57, pp.485~490 (2016)
- Foxman B, "Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden", Infect Dis Clin North Am, 28, pp.1~13 (2014)
- Foxman B, "Recurring urinary tract infection : incidence and risk factors", Am J Public Health, 80, pp.331~333 (1990)
- Ikäheimo R, "Recurrence of urinary tract infection in a primary care setting : analysis of a 1-year follow-up of 179 women", Clin Infect Dis, 22, pp.91~99 (1996)
- Sihra N, "Nonantibiotic prevention and management of recurrent urinary tract infection", Nat Rev Urol, 15, pp.750~776 (2018)
- Bonkat G, "EAU guidelines on urological infections" (2022), European Association of Urology
- Organisation for Economic Co-operation and Development, "Stemming the superbug tide: just a few dollars more" (2018), OECD
- Cai T, "The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections : to treat or not to treat?", Clin Infect Dis, 55, pp.771~777 (2012)
- KASS EH, "Asymptomatic infections of the urinary tract", Trans Assoc Am Physicians, 69, pp.56~64 (1956)
- Colgan R, "Asymptomatic bacteriuria in adults", Am Fam Physician, 74, pp.985~990 (2006)
- Nicolle LE, "Clinical practice guideline for the management of asymptomatic bacteriuria : 2019 update by the Infectious Diseases Society of America", Clin Infect Dis, 68, pp.e83~e110 (2019)
- Smaill FM, "Antibiotics for asymptomatic bacteriuria in pregnancy", Cochrane Database Syst Rev, (8), pp.CD000490~ (2015)
- Roos V, "The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine", Infect Immun, 74, pp.615~624 (2006)
- Darouiche RO, "Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder", Urology, 78, pp.341~346 (2011)
- Reid G, "Can bacterial interference prevent infection?", Trends Microbiol, 9, pp.424~428 (2001)
- The EndNote Team, "EndNote" (2013), Clarivate
- Ouzzani M, "Rayyana web and mobile app for systematic reviews", Syst Rev, 5, pp.210~ (2016)
- Sundén F, "Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying", J Urol, 184, pp.179~185 (2010)
- Darouiche RO, "Pilot trial of bacterial interference for preventing urinary tract infection", Urology, 58, pp.339~344 (2001)
- Darouiche RO, "Bacterial interference for prevention of urinary tract infection:a prospective, randomized, placebo-controlled, double-blind pilot trial", Clin Infect Dis, 41, pp.1531~1534 (2005)
- Hull R, "Urinary tract infection prophylaxis using Escherichia coli 83972in spinal cord injured patients", J Urol, 163, pp.872~877 (2000)
- Murad MH, "Rating the certainty in evidence in the absence of a single estimate of effect", Evid Based Med, 22, pp.85~87 (2017)
- Hansson S, "Untreated asymptomatic bacteriuria in girls : II--effect of phenoxymethylpenicillin and erythromycin given for intercurrent infections", BMJ, 298, pp.856~859 (1989)
- Lindberg U, "Jodal U. Asymptomatic bacteriuria in schoolgirls. VIII. clinical course during a 3-year follow-up", J Pediatr, 92, pp.194~199 (1978)
- Neugent ML, "Advances in understanding the human urinary microbiome and its potential role in urinary tract infection", mBio, 11, pp.e00218~e00220 (2020)
- Wolfe AJ, "Evidence of uncultivated bacteria in the adult female bladder", J Clin Microbiol, 50, pp.1376~1383 (2012)
- Brubaker L, "The female urinary microbiota, urinary health and common urinary disorders", Ann Transl Med, 5, pp.34~ (2017)
- Amabebe E, "The vaginal microenvironment : the physiologic role of Lactobacilli", Front Med(Lausanne), 5, pp.181~ (2018)
- Gajer P, "Temporal dynamics of the human vaginal microbiota", Sci Transl Med, 4, pp.132ra52~ (2012)
- Schwenger EM, "Probiotics for preventing urinary tract infections in adults and children", Cochrane Database Syst Rev, 2015, pp.CD008772~ (2015)
- Abdullatif VA, "Efficacy of probiotics as prophylaxis for urinary tract infections in premenopausal women : a systematic review and meta-analysis", Cureus, 13, pp.e18843~ (2021)
- Ohlemacher SI, "Enterobacteria secrete an inhibitor of Pseudomonas virulence during clinical bacteriuria", J Clin Invest, 127, pp.4018~4030 (2017)
- Klemm P, "Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972 : the taming of a pathogen", Infect Immun, 74, pp.781~785 (2006)
- Zdziarski J, "Molecular basis of commensalism in the urinary tract : low virulence or virulence attenuation?", Infect Immun, 76, pp.695~703 (2008)
- Zdziarski J, "Host imprints on bacterial genomes--rapid, divergent evolution in individual patients", PLoS Pathog, 6, pp.e1001078~ (2010)
- Wullt B, "Urodynamic factors influence the duration of Escherichia coli bacteriuria in deliberately colonized cases", J Urol, 159, pp.2057~2062 (1998)
- Trautner BW, "Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis", J Urol, 167, pp.375~379 (2002)
- Heptinstall RH, "Pathology of the kidney", pp.561~ (1974), Little, Brown and Company
- Candela JV, "Evaluation of urinary IL-1alpha and IL-1beta in gravid females and patients with bacterial cystitis and microscopic hematuria", Urol Res, 26, pp.175~180 (1998)
- Ko YC, "Elevated interleukin-8 levels in the urine of patients with urinary tract infections", Infect Immun, 61, pp.1307~1314 (1993)
- Davidoff R, "Multiple urinary cytokine levels of bacterial cystitis", J Urol, 157, pp.1980~1985 (1997)
- Grönberg-Hernández J, "Genetic control of the variable innate immune response to asymptomatic bacteriuria", PLoS One, 6, pp.e28289~ (2011)
- Benson M, "Interleukin 6 response to urinary tract infection in childhood", Pediatr Infect Dis J, 13, pp.612~616 (1994)